Is DexCom, Inc. (DXCM) A Good Stock To Buy Now? [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on DXCM. DexCom, Inc.'s share was trading at $64.62 as of April 20th. DXCM's trailing and forward P/E were 30.92 and 25.91, respectively according to Yahoo Finance. Is DXCM a good stock to buy DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. Read More: 15 AI Stocks That Are Quietly Making Investors Rich Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential DXCM has become an overlooked opportunity in the healthcare technology space, specializing in continuous glucose monitors (CGMs) that track blood sugar every few minutes without finger sticks. Historically focused on Type 1 and insulin-intensive Type 2 diabetics, DexCom derives the majority of its revenue from recurring sales of disposable sensors and trans
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1? [Yahoo! Finance]Yahoo! Finance
- Forget Ozempic: This High-Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins [Yahoo! Finance]Yahoo! Finance
- Baird Small/Mid Cap Growth Q1 2026 Commentary [Seeking Alpha]Seeking Alpha
- DXCM STOCKHOLDER NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Investors to Contact the FirmGlobeNewswire
- A Look At Dexcom (DXCM) Valuation As Shares Lag And Fair Value Estimates Point Higher [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/12/26 - Beat
DXCM
Sec Filings
- 4/16/26 - Form 4
- 4/15/26 - Form ARS
- 4/15/26 - Form DEFA14A
- DXCM's page on the SEC website